JPMorgan Chase & Co. increased its position in shares of RXO, Inc. (NYSE:RXO – Free Report) by 71.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 272,062 shares of the company’s stock after purchasing an additional 113,685 shares during the quarter. JPMorgan Chase & Co. owned 0.17% of RXO worth $7,618,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of the business. FMR LLC grew its position in RXO by 439.5% in the 3rd quarter. FMR LLC now owns 47,837 shares of the company’s stock worth $1,339,000 after purchasing an additional 38,970 shares during the last quarter. Primecap Management Co. CA increased its holdings in shares of RXO by 20.7% in the second quarter. Primecap Management Co. CA now owns 1,020,900 shares of the company’s stock valued at $26,697,000 after buying an additional 175,300 shares in the last quarter. Citigroup Inc. raised its position in shares of RXO by 132.4% during the third quarter. Citigroup Inc. now owns 196,748 shares of the company’s stock worth $5,509,000 after purchasing an additional 112,073 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in RXO by 7.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,068,380 shares of the company’s stock valued at $57,915,000 after buying an additional 136,886 shares in the last quarter. Finally, Driehaus Capital Management LLC acquired a new position in RXO in the 2nd quarter worth approximately $19,965,000. 92.73% of the stock is owned by institutional investors and hedge funds.
RXO Price Performance
NYSE:RXO opened at $24.94 on Wednesday. The firm has a market cap of $4.01 billion, a PE ratio of -12.60, a price-to-earnings-growth ratio of 15.82 and a beta of 1.52. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.21. RXO, Inc. has a 12 month low of $18.75 and a 12 month high of $32.82. The company’s 50-day moving average price is $27.02 and its two-hundred day moving average price is $27.82.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on the stock. Jefferies Financial Group lowered their price objective on shares of RXO from $33.00 to $30.00 and set a “buy” rating on the stock in a research report on Friday, January 10th. Citigroup lowered RXO from a “buy” rating to a “neutral” rating and set a $33.00 target price for the company. in a report on Tuesday, November 12th. Oppenheimer restated an “outperform” rating and set a $31.00 price target on shares of RXO in a report on Tuesday, September 17th. Susquehanna lowered their price objective on shares of RXO from $16.00 to $12.00 and set a “negative” rating on the stock in a research note on Tuesday, November 12th. Finally, The Goldman Sachs Group restated a “neutral” rating and set a $29.00 price target on shares of RXO in a research note on Monday, November 18th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $26.77.
Check Out Our Latest Report on RXO
About RXO
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Recommended Stories
- Five stocks we like better than RXO
- How Investors Can Find the Best Cheap Dividend Stocks
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- What is a support level?
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.